Innoskel Email Formats

Biotechnology Research • Sophia Antipolis, France • 1-10 Employees

Key Contact at Innoskel

Stephanie Sarrazy Garcia

Director of Discovery and Disease Models

Company overview

Headquarters	Sophia Antipolis, France
Phone number	+33442037095700
Website	innoskel.com
Founded	2020
Employees	1-10
Socials

About Innoskel

Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their voices at the heart of all they do.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Innoskel's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-01-14	4	$24,300,000

Funding Insights

$24,300,000

Total funding amount

$24,300,000

Most recent funding amount

Number of funding rounds

Innoskel Tech Stack

Discover the technologies and tools that power Innoskel's digital infrastructure, from frameworks to analytics platforms.

Plesk

Hosting panels

Sentry

Issue trackers

React Router

JavaScript frameworks

Nginx

Reverse proxies

PHP

Programming languages

Google Sign-in

Authentication

RequireJS

JavaScript frameworks

React

JavaScript frameworks

core-js

JavaScript libraries

PWA

Miscellaneous

Prototype

JavaScript frameworks

Microsoft 365

Frequently asked questions

Innoskel is located in Sophia Antipolis, FR.

You can reach Innoskel at +33442037095700.

Innoskel was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Innoskel has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Innoskel has raised a total of $24,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Innoskel

Stephanie Sarrazy Garcia

Director of Discovery and Disease Models

4.8

40,000 users